• LAST PRICE
    0.2018
  • TODAY'S CHANGE (%)
    Trending Down-0.0032 (-1.5610%)
  • Bid / Lots
    0.1950/ 10
  • Ask / Lots
    0.2050/ 1
  • Open / Previous Close
    0.2008 / 0.2050
  • Day Range
    Low 0.1921
    High 0.2064
  • 52 Week Range
    Low 0.1921
    High 1.3100
  • Volume
    486,804
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.205
TimeVolumeVIRX
09:32 ET36880.2008
09:34 ET262440.204
09:36 ET15000.20489
09:39 ET178470.2033
09:48 ET26900.206
09:50 ET52370.2041
09:52 ET24000.2023
09:54 ET1000.204086
09:56 ET2040.2023
09:57 ET52550.204
09:59 ET1790.2031
10:01 ET67260.2001
10:03 ET14700.2004
10:06 ET63540.2
10:08 ET842070.1954
10:12 ET60000.1965
10:14 ET74540.1986
10:15 ET100000.1975
10:17 ET13060.1975
10:19 ET64290.1955
10:21 ET77440.1955
10:28 ET1000.1974
10:30 ET129120.1975
10:32 ET10000.1975
10:33 ET8000.1975
10:35 ET50000.1975
10:37 ET8000.1997
10:42 ET5030.2
10:44 ET127360.2024
10:46 ET36390.2024
10:57 ET33000.2
11:00 ET86760.2063
11:04 ET49500.200101
11:06 ET51000.2
11:08 ET2000.203
11:22 ET2500.203
11:27 ET56350.2
11:33 ET293640.195
11:36 ET30000.195
11:42 ET5000.1952
11:44 ET269840.1951
11:47 ET47000.1994
12:00 ET1000.1952
12:02 ET125000.1951
12:03 ET200000.2001
12:14 ET11280.2001
12:16 ET1110.1952
12:23 ET10440.1953
12:36 ET26400.1953
12:38 ET50000.2037
12:41 ET2500.1995
12:48 ET12050.1995
12:50 ET7950.1954
12:57 ET2700.1979
01:03 ET2000.203
01:21 ET3650.203699
01:26 ET1000.203
01:30 ET4000.2
01:48 ET10000.2
01:50 ET1400.2
01:51 ET1000.2
02:00 ET2000.2
02:15 ET2500.20289
02:36 ET3000.20195
02:42 ET5000.2029
02:45 ET25370.201
02:49 ET2000.2014
02:54 ET1000.2016
03:00 ET2950.2017
03:02 ET23500.20165
03:05 ET40000.2017
03:07 ET8550.2016
03:09 ET2000.2016
03:14 ET2480.201
03:16 ET37110.2016
03:36 ET13030.2016
03:38 ET3000.2017
03:50 ET40000.204
03:57 ET11190.200101
03:59 ET48730.2018
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVIRX
Viracta Therapeutics Inc
8.1M
-0.2x
---
United StatesCYCN
Cyclerion Therapeutics Inc
8.1M
-0.7x
---
United StatesBIXT
Bioxytran Inc
7.8M
-4.8x
---
United StatesVRPX
Virpax Pharmaceuticals Inc
8.4M
-0.1x
---
United StatesABTI
Alterola Biotech Inc
7.7M
-3.2x
---
United StatesNLSP
NLS Pharmaceutics AG
7.6M
-0.5x
---
As of 2024-10-31

Company Information

Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, which impact patients worldwide. The Company’s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively, Nana-val). Nana-val is being evaluated in multiple ongoing clinical trials, including a pivotal, global, multicenter, open-label Phase II basket trial for the treatment of multiple subtypes of relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1), as well as a multinational, open-label Phase Ib/II clinical trial for the treatment of patients with recurrent or metastatic (R/M) EBV + nasopharyngeal carcinoma (NPC) and other advanced EBV + solid tumors. The Company is also pursuing the application of its Kick and Kill approach in other virus-related cancers.

Contact Information

Headquarters
2533 S COAST HWY 101, SUITE 210CARDIFF BY THE SEA, CA, United States 92007
Phone
858-400-8470
Fax
650-266-3501

Executives

Independent Chairman of the Board
Roger Pomerantz
President, Chief Executive Officer, Director
Mark Rothera
Chief Financial Officer
Michael Faerm
Senior Vice President - Finance
Melody Burcar
Chief Medical Officer
Darrel Cohen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$8.1M
Revenue (TTM)
$0.00
Shares Outstanding
39.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.71
EPS
$-1.16
Book Value
$0.47
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.